2gw5: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2gw5.gif|left|200px]]
{{Seed}}
[[Image:2gw5.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2gw5|  PDB=2gw5  |  SCENE=  }}  
{{STRUCTURE_2gw5|  PDB=2gw5  |  SCENE=  }}  


'''Crystal Structure of LIR-2 (ILT4) at 1.8 : differences from LIR-1 (ILT2) in regions implicated in the binding of the Cytomegalovirus class I MHC homolog UL18'''
===Crystal Structure of LIR-2 (ILT4) at 1.8 : differences from LIR-1 (ILT2) in regions implicated in the binding of the Cytomegalovirus class I MHC homolog UL18===




==Overview==
<!--  
BACKGROUND: Leukocyte Immunoglobulin-like Receptor-1 (LIR-1) and LIR-2 (also known as ILT2 and ILT4 respectively) are highly related cell surface receptors that bind a broad range of class I MHC molecules with low (microM) affinities. Expressed on monocytic cells and macrophages, both molecules transmit inhibitory signals after binding ligands. In addition to binding host class I MHC, the LIR-1 molecule, which is also expressed on lymphoid tissues, binds with a high (nM) affinity to UL18, a class I MHC homolog encoded by Human Cytomegalovirus (HCMV). In comparison, LIR-2 binds UL18 only weakly (microM KD). To understand how HCMV preferentially targets the more broadly expressed LIR-1 molecule, we determined the crystal structure of a ligand-binding fragment of LIR-2, and compared this to the existing high-resolution crystal structure of LIR-1. RESULTS: Recombinant LIR-2 (domains 1 and 2) was produced in E. coli and crystallized using streak seeding to optimize the crystal morphology. A data set complete to 1.8 A was collected at 100 K from a single crystal in the P4(1)2(1)2 spacegroup. The structure was solved by molecular replacement, using a search model based on the LIR-1 structure. CONCLUSIONS: The overall structure of LIR-2 D1D2 resembles both LIR-1, and Killer Inhibitory Receptors, in that the A strand in each domain forms hydrogen bonds to both beta sheets, and there is a sharp angle between the two immunoglobulin-like domains. However, differences from LIR-1 are observed in each domain, with two key changes apparent in the ligand-binding domain, D1. The region corresponding to the residue 44-57 helix of LIR-1 adopts a topology distinct from that of both LIR-1 and the KIR structures, involving a shortened 310 helix. Secondly, the predicted UL18 binding region of LIR-1 is altered substantially in LIR-2: the 76-84 loop mainchain is displaced 11 A with respect to LIR-1, and Tyrosine 38 adopts an alternative rotamer conformation. In summary, the structure of LIR-2 has revealed significant differences to LIR-1, including ones that may help to explain the &gt;1000-fold lower affinity of LIR-2 for UL18.
The line below this paragraph, {{ABSTRACT_PUBMED_12390682}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 12390682 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_12390682}}


==About this Structure==
==About this Structure==
Line 29: Line 33:
[[Category: Willcox, B E.]]
[[Category: Willcox, B E.]]
[[Category: Ig like domain]]
[[Category: Ig like domain]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 05:36:38 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 12:38:49 2008''

Revision as of 09:38, 28 July 2008

File:2gw5.png

Template:STRUCTURE 2gw5

Crystal Structure of LIR-2 (ILT4) at 1.8 : differences from LIR-1 (ILT2) in regions implicated in the binding of the Cytomegalovirus class I MHC homolog UL18

Template:ABSTRACT PUBMED 12390682

About this Structure

2GW5 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18., Willcox BE, Thomas LM, Chapman TL, Heikema AP, West AP Jr, Bjorkman PJ, BMC Struct Biol. 2002 Oct 11;2:6. PMID:12390682

Page seeded by OCA on Mon Jul 28 12:38:49 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA